Skip to main content
CollegeROIData

Updated March 2026 · College Scorecard data

Is Biotechnology Worth It?

Biotechnology holds a solid national average ROI Score of 67/100 across 1 reporting schools — Grade B territory, where repayment math works for most graduates at most institutions. Across the field, median debt is $29K against $55K in first-year earnings — a healthy debt load — repayment falls comfortably under the 8% rule on a standard 10-year plan.

Avg Debt
$29K
Avg Year 1 Earnings
$55K
Avg Year 5 Earnings
$74K
Avg ROI Score
67/100

Biotechnology ROI at a Glance

holds a solid national average ROI Score of 67/100 across 1 reporting schools — Grade B territory, where repayment math works for most graduates at most institutions. The graduation-weighted average across reporting institutions is the cleanest single number for the field, but it hides the spread — top programs like Bay Path University run far ahead of the bottom of the table. School choice within Biotechnology matters because the major-level number is a starting point, not a prediction.

Earnings rise sharply from $55K in year 1 to $74K by year 5 — 35% growth in four years. That is a strong promotion curve, common in technology, engineering, and finance tracks where early-career skill compounding pays off fast. The five-year earnings trajectory is one of the strongest signals of long-run career fit; a flat curve suggests the major leads to roles where seniority does not pay off without graduate credentials, while a steep curve indicates fast skill compounding inside the field.

Best in field: Bay Path University leads the field with a 67/100 ROI Score (Grade B). Median debt at completion is $29K against $55K in first-year earnings — a debt-to-income ratio of 0.53x. Worst in field: Bay Path University sits at the bottom of the field with a 67/100 ROI Score (Grade B). Median debt at completion is $29K against $55K in first-year earnings — a debt-to-income ratio of 0.53x.

Debt-to-Income at the Field Level

At a debt-to-earnings ratio of 0.53x, Biotechnology shows a healthy debt load — repayment falls comfortably under the 8% rule on a standard 10-year plan. Federal financial-aid research uses the “8% rule” — monthly student loan payments under 8% of gross monthly income — which translates to debt below roughly 0.75x annual earnings on a standard 10-year plan. Programs running above 1.0x typically need income-driven repayment to stay current; above 1.5x, the math rarely works without forgiveness mechanics or an unusually steep career ramp. For borrower-rights and repayment guidance, the Consumer Financial Protection Bureau is the most accessible federal source.

Debt vs Earnings by School

Biotechnology by School

SchoolStateMedian DebtYear 1 EarningsYear 5 EarningsROI GradeVerdict
Bay Path UniversityMa$29K$55K$74KBBUY

How Biotechnology’s ROI Score Is Calculated

The Biotechnology ROI Score is a weighted composite of five financial-aid signals: debt-to-income (35%), earnings premium over a high-school diploma (25%), 10-year BLS job-growth outlook (20%), graduation rate (10%), and debt vs. the national average (10%). Each school + major combination is scored individually, then aggregated up to the field level. The grade thresholds (A ≥ 80, B ≥ 65, C ≥ 50, D ≥ 35, F < 35) are calibrated so a typical break-even degree lands in the C range. Read the full methodology.

Frequently Asked Questions

Is a Biotechnology degree worth it?

Biotechnology holds a solid national average ROI Score of 67/100 across 1 reporting schools — Grade B territory, where repayment math works for most graduates at most institutions. The dominant signal is debt-to-income: at a debt-to-earnings ratio of 0.53x on average, the field shows a healthy debt load — repayment falls comfortably under the 8% rule on a standard 10-year plan. Outcomes vary sharply by institution, so the school you choose within Biotechnology usually matters more than the major label itself.

What is the average debt for a Biotechnology degree?

Median debt at completion across the 1 U.S. schools reporting Biotechnology data to the College Scorecard is $29K, against a national all-major average of $26K. The range across schools is wide — $29K at the top of the table to $29K at the bottom.

How much do Biotechnology graduates earn?

Earnings rise sharply from $55K in year 1 to $74K by year 5 — 35% growth in four years. That is a strong promotion curve, common in technology, engineering, and finance tracks where early-career skill compounding pays off fast. National average first-year earnings across all 30,224 school + major combinations on the site is $58K — for context, Biotechnology sits below that benchmark.

Which school has the best Biotechnology program by ROI?

Bay Path University leads the field with a 67/100 ROI Score (Grade B). Median debt at completion is $29K against $55K in first-year earnings — a debt-to-income ratio of 0.53x. On the other end, Bay Path University sits at the bottom of the field with a 67/100 ROI Score (Grade B). Median debt at completion is $29K against $55K in first-year earnings — a debt-to-income ratio of 0.53x.

Where does this Biotechnology data come from?

Every figure on this page comes from federal public datasets — the U.S. Department of Education College Scorecard (collegescorecard.ed.gov) for debt and earnings, IPEDS (nces.ed.gov/ipeds) for graduation rates, and BLS Employment Projections for the job-growth outlook component of the ROI Score. Borrower-rights guidance: the Consumer Financial Protection Bureau (consumerfinance.gov). The dataset was last refreshed March 2026.

Sources: U.S. Department of Education College Scorecard and IPEDS, Bureau of Labor Statistics Employment Projections, Consumer Financial Protection Bureau. All federal datasets are public domain.

Last updated 2026-03-15 · 1 schools reporting for this major.